tradingkey.logo

BRIEF-Advancell Enters Into Strategic Collaboration With Lilly To Advance Therapies For The Treatment Of Cancer

ReutersFeb 10, 2025 1:18 PM

- Eli Lilly LLY.N:

  • ADVANCELL ENTERS INTO STRATEGIC COLLABORATION WITH LILLY TO ADVANCE NOVEL TARGETED ALPHA THERAPIES FOR THE TREATMENT OF CANCER

  • ADVANCELL: TO EXPLORE THE POTENTIAL OF PB-212-BASED ALPHA THERAPIES WITH LILLY

Further company coverage: LLY.N

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI